modifier subunit gclm Search Results


gclm  (Boster Bio)
91
Boster Bio gclm
(A) The protein expression of HO-1, <t>NQO1,</t> <t>GCLc,</t> <t>GCLm,</t> TrxR1 and Keap1 was detected by western blot (B) The expressing levels of proteins relate to antioxidant/phase II detoxification enzymes. All data represent mean ± SD. * p ≤ 0.05 and ** p ≤ 0.01 compared to the control group.
Gclm, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gclm/product/Boster Bio
Average 91 stars, based on 1 article reviews
gclm - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier
emsa kit, including biotinylated epre probe from the human glutamate–cysteine ligase, modifier subunit (gclm) promoter  (Panomics Inc)
90
Panomics Inc emsa kit, including biotinylated epre probe from the human glutamate–cysteine ligase, modifier subunit (gclm) promoter
Age-dependent alteration in protein binding to the GCLM EpRE. Protein extracts from lung samples of young (6-month-old) and middle-aged (21-month-old) mice were analyzed for their ability to bind to <t>a</t> <t>biotinylated</t> EpRE from human GCLM promoter with <t>EMSA</t> (gel-shift) assay as described in . (A) Age-increased EpRE binding. Representative blot and band densitometry results ( N =5);⁎, p -value<0.05, (Rank sum test). (B) Immunodepletion experiments to determine relative contribution of Nrf1, Nrf2, and Bach1 to the probe. Percentage of immunodepletion (compared to IgG) is shown ( N =5); ⁎, p -value=0.056, n.s., not significantly different (Rank sum test).
Emsa Kit, Including Biotinylated Epre Probe From The Human Glutamate–Cysteine Ligase, Modifier Subunit (Gclm) Promoter, supplied by Panomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/emsa kit, including biotinylated epre probe from the human glutamate–cysteine ligase, modifier subunit (gclm) promoter/product/Panomics Inc
Average 90 stars, based on 1 article reviews
emsa kit, including biotinylated epre probe from the human glutamate–cysteine ligase, modifier subunit (gclm) promoter - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
primary antibodies used in these studies were against glutamate cysteine ligase catalytic (gclc) or glutamyl-modifier (gclm) subunits ( 9 )  (Becton Dickinson)
90
Becton Dickinson primary antibodies used in these studies were against glutamate cysteine ligase catalytic (gclc) or glutamyl-modifier (gclm) subunits ( 9 )
Age-dependent alteration in protein binding to the GCLM EpRE. Protein extracts from lung samples of young (6-month-old) and middle-aged (21-month-old) mice were analyzed for their ability to bind to <t>a</t> <t>biotinylated</t> EpRE from human GCLM promoter with <t>EMSA</t> (gel-shift) assay as described in . (A) Age-increased EpRE binding. Representative blot and band densitometry results ( N =5);⁎, p -value<0.05, (Rank sum test). (B) Immunodepletion experiments to determine relative contribution of Nrf1, Nrf2, and Bach1 to the probe. Percentage of immunodepletion (compared to IgG) is shown ( N =5); ⁎, p -value=0.056, n.s., not significantly different (Rank sum test).
Primary Antibodies Used In These Studies Were Against Glutamate Cysteine Ligase Catalytic (Gclc) Or Glutamyl Modifier (Gclm) Subunits ( 9 ), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies used in these studies were against glutamate cysteine ligase catalytic (gclc) or glutamyl-modifier (gclm) subunits ( 9 )/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
primary antibodies used in these studies were against glutamate cysteine ligase catalytic (gclc) or glutamyl-modifier (gclm) subunits ( 9 ) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
biotinylated dsdna epre probe of the human glutamate-cysteine ligase, modifier subunit ( gclm ) promoter  (Panomics Inc)
90
Panomics Inc biotinylated dsdna epre probe of the human glutamate-cysteine ligase, modifier subunit ( gclm ) promoter
Age-dependent alteration in protein binding to the GCLM EpRE. Protein extracts from lung samples of young (6-month-old) and middle-aged (21-month-old) mice were analyzed for their ability to bind to <t>a</t> <t>biotinylated</t> EpRE from human GCLM promoter with <t>EMSA</t> (gel-shift) assay as described in . (A) Age-increased EpRE binding. Representative blot and band densitometry results ( N =5);⁎, p -value<0.05, (Rank sum test). (B) Immunodepletion experiments to determine relative contribution of Nrf1, Nrf2, and Bach1 to the probe. Percentage of immunodepletion (compared to IgG) is shown ( N =5); ⁎, p -value=0.056, n.s., not significantly different (Rank sum test).
Biotinylated Dsdna Epre Probe Of The Human Glutamate Cysteine Ligase, Modifier Subunit ( Gclm ) Promoter, supplied by Panomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotinylated dsdna epre probe of the human glutamate-cysteine ligase, modifier subunit ( gclm ) promoter/product/Panomics Inc
Average 90 stars, based on 1 article reviews
biotinylated dsdna epre probe of the human glutamate-cysteine ligase, modifier subunit ( gclm ) promoter - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
primers glutamate-cysteine ligase modifier subunit (gclm  (G Biosciences)
90
G Biosciences primers glutamate-cysteine ligase modifier subunit (gclm
Age-dependent alteration in protein binding to the GCLM EpRE. Protein extracts from lung samples of young (6-month-old) and middle-aged (21-month-old) mice were analyzed for their ability to bind to <t>a</t> <t>biotinylated</t> EpRE from human GCLM promoter with <t>EMSA</t> (gel-shift) assay as described in . (A) Age-increased EpRE binding. Representative blot and band densitometry results ( N =5);⁎, p -value<0.05, (Rank sum test). (B) Immunodepletion experiments to determine relative contribution of Nrf1, Nrf2, and Bach1 to the probe. Percentage of immunodepletion (compared to IgG) is shown ( N =5); ⁎, p -value=0.056, n.s., not significantly different (Rank sum test).
Primers Glutamate Cysteine Ligase Modifier Subunit (Gclm, supplied by G Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primers glutamate-cysteine ligase modifier subunit (gclm/product/G Biosciences
Average 90 stars, based on 1 article reviews
primers glutamate-cysteine ligase modifier subunit (gclm - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
human glutamate cysteine ligase, modifier subunit (gclm) elisa kit  (Bioss)
N/A
   Buy from Supplier
mouse glutamate cysteine ligase, modifier subunit (gclm) elisa kit  (Bioss)
N/A
   Buy from Supplier
glutamate cysteine ligase modifier subunit gclm antibody  (Abbexa)
N/A
GCLM Antibody is a Rabbit Polyclonal against GCLM
   Buy from Supplier
rat glutamate cysteine ligase, modifier subunit (gclm) elisa kit  (Bioss)
N/A
   Buy from Supplier

Image Search Results


(A) The protein expression of HO-1, NQO1, GCLc, GCLm, TrxR1 and Keap1 was detected by western blot (B) The expressing levels of proteins relate to antioxidant/phase II detoxification enzymes. All data represent mean ± SD. * p ≤ 0.05 and ** p ≤ 0.01 compared to the control group.

Journal: Frontiers in Pharmacology

Article Title: Formononetin Improves the Survival of Random Skin Flaps Through PI3K/Akt-Mediated Nrf2 Antioxidant Defense System

doi: 10.3389/fphar.2022.901498

Figure Lengend Snippet: (A) The protein expression of HO-1, NQO1, GCLc, GCLm, TrxR1 and Keap1 was detected by western blot (B) The expressing levels of proteins relate to antioxidant/phase II detoxification enzymes. All data represent mean ± SD. * p ≤ 0.05 and ** p ≤ 0.01 compared to the control group.

Article Snippet: Primary antibodies against NQO1, TrxR1, HO-1, Keap1 IL-1β, TNF-α and Lamin B were from Abcam (Cambridge, UK); antibodies against GCLc and GCLm were purchased from Boster Biological Technology (Wuhan, China); antibodies against Nrf2, GAPDH, PI3K, P-Pi3k, AKT, and P-AKT were purchased from Cell Signaling Technologies (Danvers, MA, United States); antibodies directed vascular endothelial growth factor (VEGF) and SOD2 were obtained from Affinity Biosciences (Cincinnati, OH, United States).

Techniques: Expressing, Western Blot, Control

(A,B) Western blot along with its quantification revealed that the level of P-PI3K, P-Akt and Nrf2 as treated above (C,D) Western blot along with its quantification revealed that the level of HO-1, NQO1, GCLc, GCLm and TrxR1 (E,F) The IHC result of SOD2 and HO-1 expression in skin flaps (scale bar: 50 μm) ** p ≤ 0.01 compared to the control group; ## p ≤ 0.01 compared to the FMNT-H group.

Journal: Frontiers in Pharmacology

Article Title: Formononetin Improves the Survival of Random Skin Flaps Through PI3K/Akt-Mediated Nrf2 Antioxidant Defense System

doi: 10.3389/fphar.2022.901498

Figure Lengend Snippet: (A,B) Western blot along with its quantification revealed that the level of P-PI3K, P-Akt and Nrf2 as treated above (C,D) Western blot along with its quantification revealed that the level of HO-1, NQO1, GCLc, GCLm and TrxR1 (E,F) The IHC result of SOD2 and HO-1 expression in skin flaps (scale bar: 50 μm) ** p ≤ 0.01 compared to the control group; ## p ≤ 0.01 compared to the FMNT-H group.

Article Snippet: Primary antibodies against NQO1, TrxR1, HO-1, Keap1 IL-1β, TNF-α and Lamin B were from Abcam (Cambridge, UK); antibodies against GCLc and GCLm were purchased from Boster Biological Technology (Wuhan, China); antibodies against Nrf2, GAPDH, PI3K, P-Pi3k, AKT, and P-AKT were purchased from Cell Signaling Technologies (Danvers, MA, United States); antibodies directed vascular endothelial growth factor (VEGF) and SOD2 were obtained from Affinity Biosciences (Cincinnati, OH, United States).

Techniques: Western Blot, Expressing, Control

Age-dependent alteration in protein binding to the GCLM EpRE. Protein extracts from lung samples of young (6-month-old) and middle-aged (21-month-old) mice were analyzed for their ability to bind to a biotinylated EpRE from human GCLM promoter with EMSA (gel-shift) assay as described in . (A) Age-increased EpRE binding. Representative blot and band densitometry results ( N =5);⁎, p -value<0.05, (Rank sum test). (B) Immunodepletion experiments to determine relative contribution of Nrf1, Nrf2, and Bach1 to the probe. Percentage of immunodepletion (compared to IgG) is shown ( N =5); ⁎, p -value=0.056, n.s., not significantly different (Rank sum test).

Journal: Redox Biology

Article Title: Competition of nuclear factor-erythroid 2 factors related transcription factor isoforms, Nrf1 and Nrf2, in antioxidant enzyme induction ☆

doi: 10.1016/j.redox.2013.01.005

Figure Lengend Snippet: Age-dependent alteration in protein binding to the GCLM EpRE. Protein extracts from lung samples of young (6-month-old) and middle-aged (21-month-old) mice were analyzed for their ability to bind to a biotinylated EpRE from human GCLM promoter with EMSA (gel-shift) assay as described in . (A) Age-increased EpRE binding. Representative blot and band densitometry results ( N =5);⁎, p -value<0.05, (Rank sum test). (B) Immunodepletion experiments to determine relative contribution of Nrf1, Nrf2, and Bach1 to the probe. Percentage of immunodepletion (compared to IgG) is shown ( N =5); ⁎, p -value=0.056, n.s., not significantly different (Rank sum test).

Article Snippet: The EMSA kit, including biotinylated EpRE probe from the human glutamate–cysteine ligase, modifier subunit ( gclm ) promoter was purchased from (Panomics, Fremont, CA).

Techniques: Protein Binding, Gel Shift, Binding Assay, Immunodepletion